Brief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
23/07/2026 02:37
BRIEF-Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets July 23 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX:
CLINUVEL STRATEGIC REORGANISATION TO REFOCUS ON U.S. MARKETS
TO RELOCATE CORPORATE HEADQUARTERS TO UNITED STATES EFFECTIVE 1 JANUARY 2027
TO REDUCE GLOBAL WORKFORCE BY 10%-20% AND RELOCATE FUNCTIONS TO U.S.
TO FOCUS OPERATIONAL RESOURCES ON U.S. PHARMACEUTICAL PIPELINE AND STRATEGY
RESTRUCTURING TO ENABLE ACCESS TO DEEPER U.S. CAPITAL POOLS
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist